Forward Citations = 149
Company Filing History:
Andreas Strüngmann, a German businessman, founded generic drug maker Hexal AG in 1986. Under his visionary leadership, Hexal became Germany’s second-largest generic drug producer, achieving $1.6 billion in sales during 20041. Andreas, along with his twin brother Thomas Strüngmann, played a crucial role in the success of BioNTech, which partnered with Pfizer to develop a Covid-19 vaccine. The brothers also invest in biotech, pharma, life sciences, and healthcare companies through their Zug-based investment firm, Santo Holding.
Get your Inventor Badge Today